
|Articles|July 1, 1999
Supplements and Featured Publications
- Evaluating the Health Benefits of Atypical Agents in the Treatment and Management of Psychoses
- Volume 5
- Issue 10 Suppl
Assessment of Quality-of-Life Outcomes in Schizophrenic Patients
Author(s)Anthony F. Lehman, MD, MSPH
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
Introductionover 26 years ago
The Emerging Role of Psychiatric Pharmacistsover 26 years ago
CME/CE Quizover 26 years ago
Selected Abstractsover 26 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
3
Adolescents, Young Adults Use AI Chatbots for Mental Health Advice
4
Aligning Incentives Could Increase Access to Lower-Cost Surgery Sites: Xiaoxi Zhao, PhD
5
















































